Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema

BMC Ophthalmology

Volumn 8, Issue , 2008, Pages

  Cellini, Mauro ^a   Pazzaglia, Alberto ^a   Zamparini, Eugenio ^a   Leonetti, Pietro ^a   Campos, Emilio C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INSULIN TREATMENT; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA CYSTOID EDEMA; STATISTICAL SIGNIFICANCE; THICKNESS; TREATMENT DURATION; VISUAL ACUITY; COMPARATIVE STUDY; CONNECTIVE TISSUE; DIABETIC RETINOPATHY; FOLLOW UP; INJECTION; PATHOLOGY; RETINA MACULA EDEMA; RETINA MACULA LUTEA; TREATMENT OUTCOME; VITREOUS BODY;

CONNECTIVE TISSUE; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULA LUTEA; MACULAR EDEMA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 41549088806     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-8-5     Document Type: Article

References (41)

1. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. R Klein BE Klein SE Moss, Ophthalmology 1984 91 1464 1474 6521986
2. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985 103 1796 1806 2866759
3. Perspectives on diabetic retinopathy. LM Aiello, Am J Ophthalmol 2003 136 122 135 10.1016/S0002-9394(03)00219-8 12834680
4. Laser photocoagulation of diabetic macular edema. L Akduman RJ Olk, Ophthalmic Surg Lasers 1997 28 387 408 9150523
5. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. P Massin F Audren B Haouchine, Ophthalmology 2004 111 218 24 10.1016/j.ophtha.2003.05.037 15019365
6. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. JB Jonas I Kreissig A Sofker RF Degenring, Arch Ophthalmol 2003 121 57 61 10.1001/archopht.121.5.729 12523885
7. Intravitreal triamcinolone for refractory diabetic macular edema. A Martidis JS Duker PB Greenberg, Ophthalmology 2002 109 920 927 10.1016/S0161-6420(02)00975-2 11986098
8. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. DM Moshfeghi PK Kaiser IU Scott, Am J Ophthalmol 2003 136 791 796 10.1016/S0002-9394(03)00483-5 14597028
9. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. JB Jonas I Kreissig R Degenring, Arch Ophthalmol 2003 121 729 730 10.1001/archopht.121.5.729 12742856
10. The effects of posterior subtenon injection of triamcinolone actetonide in patients with intermediate uveitis. CJ Helm GN Holland, Am J Ophthalmol 1995 120 55 64 7611330
11. A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. AB Thach PU Dugel RJ Flindall, Ophthalmology 1997 104 2003 2008 9400758
12. Transcleral drug delivery for posterior segment disease. DH Geroski HF Edelhauser, Adv Drug Deliv Rev 2001 52 37 48 10.1016/S0169-409X(01)00193-4 11672874
13. Ten-year incidence of visual loss in a diabetic population. SE Moss R Klein BE Klein, Ophthalmology 1994 101 6 1061 1070 8008348
14. The 14-year incidence of visual loss in a diabetic population. SE Moss R Klein BE Klein, Ophthalmology 1998 105 6 998 1003 10.1016/S0161-6420(98)96025-0 9627648
15. The potential role of PTK beta in diabetic retinopathy and macular edema. LP Aiello, Surv Ophthalmol 2002 47 suppl S263 9 10.1016/S0039-6257(02)00391-0
16. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. B Sander M Larsen B Moldow H Lund-Andersen, Invest Ophthalmol Vis Sci 2001 42 433 438 11157879
17. Macular edema: the role of soluble mediators. D Kent SA Vinores PA Campochiaro, Br J Ophthalmol 2000 84 542 545 10781524 10.1136/bjo.84.5.542
18. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology 1987 94 761 774 3658348
19. Modified grid laser photocoagulation for diffuse macular edema: long-term visual results. CM Lee RJ Olk, Ophthalmology 1991 98 1594 1602 1961650
20. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no.19. Arch Ophthalmol 1995 113 1144 1155 7661748
21. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. A Nanoka J Kiryu A Tsujikawa, Invest Ophthalmol Vis Sci 2002 43 1204 1209 11923267
22. Correlation of a scanninig laser derived edema index and visual function following grid laser treatment for diabetic macular edema. C Hudson JG Flanagan GS Turner, Br J Ophthalmol 2003 87 455 461 12642310 10.1136/bjo.87.4.455
23. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. FC Barouch K Miyamoto JR Allport, Invest Ophthamol Vis Sci 2000 41 5 1153 1158 10752954
24. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. E Miyamoto S Khosrof SE Bursell, Proc Natl Acad Sci USA 1999 96 10836 10841 10485912 10.1073/pnas.96.19.10836
25. Retinal expression. regulation. and functional bioactivity of prostacyclin-stimulating factor. Y Hata A Clermont T Yamauchi, J Clin Invest 2000 106 541 550 10953029 10.1172/JCI8338
26. New surgical approach for removing foveal hard exudates in diabetic macular edema. H Takagi A Otani J Kiryu Y Ogura, Ophthalmology 1999 106 249 256 10.1016/S0161-6420(99)90054-4 9951473
27. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. B Tesfamariam ML Brown RA Cohen, J Clin Invest 1991 87 1643 1648 2022734 10.1172/JCI115179
28. Acute effects of glucose on reactivity of cerebral microcirculation: role of activation of protein kinase C. WG Mayhan KP Patel, Am J Physiol 1995 269 4 11297 11302 7485561
29. High Glucose Causes Upregulation of Cyclooxygenase-2 and alters Prostanoid Profile in Human Endothelial Cells. Role of Protein Kinase C and Reactive Oxygen Species. F Casentino P De Paolis B van der Loo M Bachschmid V Ullrich A Kouroedov C Delli Gatti H Joch M Volpe TF Lüscher, Circulation 2003 107 1017 1023 10.1161/01.CIR.0000051367.92927.07 12600916
30. Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells. S Hara A Miyata C Yokoyama, J Biol Chem 1994 269 19897 19903 8051072
31. Human vitreal prostaglandin levels and proliferative diabetic retinopathy. S Douros BA Phillips A Nadel SA Obstbaum, Doc Ophthalmol 2001 103 1 27 34 10.1023/A:1017557600233 11678158
32. Diabetic retinopathy and laser flare cell-meter. M Cellini A Baldi B Bernabini P Leonetti EC Campos, It Ophthalmol Bull 2005 84 95 102
33. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. CA Wilson BA Berkowitz Y Sato, Arch Ophthalmol 1992 110 1155 1159 1497531
34. Intravitreal triamcinolone and elevated intraocular pressure. RJ Wingate PE Beaumont, Aust N Z J Ophthalmol 1999 27 431 432 10.1046/j.1440-1606.1999. 00238.x 10641903
35. Intravitreal triamcinolone acetonide and intraocular pressure. LM Smithen MD Ober L Maranan RF Spaide, Am J Ophthalmol 2004 138 740 743 10.1016/j.ajo.2004.06.067 15531307
36. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. PM Beer JS Bakri RJ Singh, Ophthalmology 2003 110 681 686 10.1016/S0161-6420(02)01969-3 12689886
37. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection. M Inoue K Takeda K Morita, Am J Ophthalmol 2004 138 1046 1048 10.1016/j.ajo.2004.05.028 15629301
38. Echographic localization of corticosteroids after periocular injection. WR Freeman RL Green RE Smith, Am J Ophthalmol 1987 103 281 288 3548390
39. The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure. AJ Mueller G Jian AS Banker, Am J Ophthalmol 1998 125 158 163 10.1016/S0002-9394(99)80085-3 9467440
40. Intravitreal Triamcinolone Acetonide concentration after subtenon injection. ER Thomas J Wang E Ege R Madsen DP Hainsworth, Am J Ophthalmol 2006 142 860 861 10.1016/j.ajo.2006.05.023 17056371
41. Conjunctival ulceration following triamcinolone injection. S Agrawal J Agrawal TP Agrawal, Am J Ophthalmol 2003 136 539 540 10.1016/S0002-9394(03) 00320-9 12967811